Schnitzler M |
Diabetes mellitus after kidney transplantation in the United States. |
2003 |
Am. J. Transplant. |
pmid:14510709
|
Woodward RS et al. |
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. |
2003 |
Am. J. Transplant. |
pmid:12752315
|
Kim EJ et al. |
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. |
2014 |
Am. J. Transplant. |
pmid:24354871
|
Frassetto LA et al. |
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17949460
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Dugast E et al. |
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27367750
|
Tang Q |
Pharmacokinetics of therapeutic Tregs. |
2014 |
Am. J. Transplant. |
pmid:25358900
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Sikma MA et al. |
Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. |
2015 |
Am. J. Transplant. |
pmid:26053114
|
English RF et al. |
Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12243498
|
de Fontbrune FS et al. |
Veno-occlusive disease of the liver after lung transplantation. |
2007 |
Am. J. Transplant. |
pmid:17697264
|
Kurtz J et al. |
Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L. |
2003 |
Am. J. Transplant. |
pmid:12814472
|
Krenzien F et al. |
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:27754593
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Ekberg H et al. |
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19563339
|
ter Meulen CG et al. |
Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. |
2004 |
Am. J. Transplant. |
pmid:15084178
|
Mehra MR et al. |
Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter. |
2006 |
Am. J. Transplant. |
pmid:16686745
|
Grimm M et al. |
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial. |
2006 |
Am. J. Transplant. |
pmid:16686762
|
Sis B et al. |
Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. |
2006 |
Am. J. Transplant. |
pmid:16686769
|
Hernández-Fisac I et al. |
Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets. |
2007 |
Am. J. Transplant. |
pmid:17725683
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
Bouamar R et al. |
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). |
2013 |
Am. J. Transplant. |
pmid:23480233
|
Busque S et al. |
The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. |
2011 |
Am. J. Transplant. |
pmid:21943027
|
Hamdy AF et al. |
Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. |
2005 |
Am. J. Transplant. |
pmid:16162204
|
Kaufman DB et al. |
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results. |
2005 |
Am. J. Transplant. |
pmid:16162205
|
Mujtaba MA et al. |
Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. |
2014 |
Am. J. Transplant. |
pmid:25179306
|
Schwarz A et al. |
Polyoma virus nephropathy in native kidneys after lung transplantation. |
2005 |
Am. J. Transplant. |
pmid:16162212
|
Flechner SM et al. |
Allotransplantation of cryopreserved parathyroid tissue for severe hypocalcemia in a renal transplant recipient. |
2010 |
Am. J. Transplant. |
pmid:20883540
|
BenÃtez CE et al. |
ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20883560
|
Böger CA et al. |
Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity. |
2006 |
Am. J. Transplant. |
pmid:16889550
|
Tan HP et al. |
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. |
2006 |
Am. J. Transplant. |
pmid:16889606
|
Lucey MR et al. |
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. |
2005 |
Am. J. Transplant. |
pmid:15816894
|
Pillebout E et al. |
Renal histopathological lesions after orthotopic liver transplantation (OLT). |
2005 |
Am. J. Transplant. |
pmid:15816895
|
Hirsch HH et al. |
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
2016 |
Am. J. Transplant. |
pmid:26639422
|
Chisholm-Burns MA et al. |
Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. |
2013 |
Am. J. Transplant. |
pmid:23819827
|
Van Laecke S et al. |
Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19624560
|
Pescovitz MD et al. |
A randomized, double-blind, pharmacokinetic study of oral maribavir with tacrolimus in stable renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19663892
|
Mian AN et al. |
Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. |
2005 |
Am. J. Transplant. |
pmid:15636628
|
Gregoor PS and Weimar W |
Tacrolimus and pure red-cell aplasia. |
2005 |
Am. J. Transplant. |
pmid:15636632
|
Bohl DL et al. |
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. |
2005 |
Am. J. Transplant. |
pmid:16095500
|
Kasahara M et al. |
Living-donor liver transplantation for hepatoblastoma. |
2005 |
Am. J. Transplant. |
pmid:16095502
|
Lemahieu WP et al. |
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095503
|
Gao R et al. |
Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. |
2007 |
Am. J. Transplant. |
pmid:17391142
|
Meier-Kriesche HU and Kaplan B |
Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune. |
2002 |
Am. J. Transplant. |
pmid:12095048
|
Rodriguez-Rodriguez AE et al. |
The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. |
2013 |
Am. J. Transplant. |
pmid:23651473
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Padiyar A et al. |
Clinical predictors of proteinuria after conversion to sirolimus in kidney transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20055793
|
Neuberger JM et al. |
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. |
2009 |
Am. J. Transplant. |
pmid:19120077
|
Momper JD et al. |
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. |
2011 |
Am. J. Transplant. |
pmid:21714845
|
Tan HP et al. |
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. |
2009 |
Am. J. Transplant. |
pmid:19120078
|
Ashman N et al. |
Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. |
2009 |
Am. J. Transplant. |
pmid:19120084
|
Lemahieu WP et al. |
CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. |
2004 |
Am. J. Transplant. |
pmid:15307840
|
Vongwiwatana A et al. |
Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. |
2004 |
Am. J. Transplant. |
pmid:14678043
|
Bressollette-Bodin C et al. |
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996241
|
Augustine JJ et al. |
Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996247
|
Filler G et al. |
Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. |
2005 |
Am. J. Transplant. |
pmid:15996252
|
Fan DM et al. |
Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. |
2015 |
Am. J. Transplant. |
pmid:25808777
|
Awadalla Y et al. |
HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. |
2004 |
Am. J. Transplant. |
pmid:15367226
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Dahm F et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15575921
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
Okabayashi T et al. |
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. |
2011 |
Am. J. Transplant. |
pmid:21883903
|
Hellemons ME et al. |
Former smoking is a risk factor for chronic kidney disease after lung transplantation. |
2011 |
Am. J. Transplant. |
pmid:21883906
|
Luan FL et al. |
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. |
2008 |
Am. J. Transplant. |
pmid:18786231
|
Woywodt A et al. |
Different preparations of tacrolimus and medication errors. |
2008 |
Am. J. Transplant. |
pmid:18786238
|
Levi Z et al. |
Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. |
2007 |
Am. J. Transplant. |
pmid:17229076
|
Mulay AV et al. |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. |
2009 |
Am. J. Transplant. |
pmid:19353768
|
Ogawa T et al. |
Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model. |
2007 |
Am. J. Transplant. |
pmid:17229077
|
Miriuka SG et al. |
mTOR inhibition induces endothelial progenitor cell death. |
2006 |
Am. J. Transplant. |
pmid:16796720
|
Bourdeaux C et al. |
Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. |
2007 |
Am. J. Transplant. |
pmid:17173657
|
Mazariegos GV et al. |
Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. |
2005 |
Am. J. Transplant. |
pmid:15643991
|
Bahra M et al. |
MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course. |
2005 |
Am. J. Transplant. |
pmid:15644002
|
Zheng H et al. |
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. |
2003 |
Am. J. Transplant. |
pmid:12694072
|
Montgomery SP et al. |
Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. |
2002 |
Am. J. Transplant. |
pmid:12118862
|
Ahsan N et al. |
Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. |
2002 |
Am. J. Transplant. |
pmid:12118902
|
Rostaing L et al. |
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. |
2013 |
Am. J. Transplant. |
pmid:23730730
|
van Hooff JP et al. |
Glucose metabolic disorder after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17511670
|
Heffron TG et al. |
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17511684
|
Moench C et al. |
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17511685
|
Patlolla V et al. |
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17564638
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
Levy G et al. |
REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C. |
2014 |
Am. J. Transplant. |
pmid:24456049
|
McDonald RA et al. |
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. |
2008 |
Am. J. Transplant. |
pmid:18416737
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Posselt AM et al. |
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. |
2010 |
Am. J. Transplant. |
pmid:20659093
|
Teuteberg JJ et al. |
Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. |
2010 |
Am. J. Transplant. |
pmid:19889126
|
Ciancio G et al. |
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. |
2012 |
Am. J. Transplant. |
pmid:22946986
|
Jacobson PA et al. |
Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs. |
2012 |
Am. J. Transplant. |
pmid:22947444
|
Shapiro R et al. |
Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17908272
|
De Simone P et al. |
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. |
2012 |
Am. J. Transplant. |
pmid:22882750
|
Echeverri GJ et al. |
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. |
2009 |
Am. J. Transplant. |
pmid:19775318
|
Gaston RS et al. |
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. |
2009 |
Am. J. Transplant. |
pmid:19459794
|
Turgut F and Akcay A |
Renal function estimation in cirrhosis. |
2009 |
Am. J. Transplant. |
pmid:19519814
|
Irish WD et al. |
Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database. |
2011 |
Am. J. Transplant. |
pmid:21564522
|
Tricot L et al. |
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. |
2009 |
Am. J. Transplant. |
pmid:19519819
|
Friman S et al. |
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21564523
|
Kofler S et al. |
Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study. |
2009 |
Am. J. Transplant. |
pmid:19519820
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|
Brennan DC et al. |
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. |
2005 |
Am. J. Transplant. |
pmid:15707414
|
Rogers J et al. |
Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. |
2003 |
Am. J. Transplant. |
pmid:14510702
|